Humedix Co., Ltd. (200670.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩22,950 (+1.10%) as of
Key statistics
- Market cap
- 252.48B
- Forward P/E
- 5.63
- Dividend yield
- 5.15%
- 52-week range
- 21,050.00 – 52,700.00
- Beta
- 0.37
- Revenue (TTM)
- 110.99B
- Profit margin
- 8.17%
- Analyst target
- ₩62,000
- Volume
- 15.21k
About Humedix Co., Ltd.
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seongnam-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.